Vuity is our first FDA-approved pharmaceutical agent labeled for the treatment of a refractive error, presbyopia.
Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%, Allergan) has now been on the market for 6 months. I would like to share a few personal learnings. I want to disclose that I consult widely in the field of refractive error correction including contact lenses, corneal and lens-based refractive surgery, and pharmaceuticals, including miotic drops and other topical agents for presbyopia and myopia.
First, presbyopia is another refractive error like myopia, hyperopia and